Device / Technology News

RSS

HITRUST designates PwC as a Common Security Framework Assessor

PwC US announced today that the Health Information Trust Alliance (HITRUST) has designated the firm a Common Security Framework (CSF) Assessor, qualified to evaluate and certify security standards of CSF-related services.

11 Jan 2011

Stereotaxis announces first successful cardiac ablation procedure with Vdrive robotic navigation system

Stereotaxis, Inc. announces the first successful cardiac ablation procedure with the Vdrive™ robotic navigation system as the company received CE Mark for this latest innovation.

11 Jan 2011

AccessClosure launches Mynx Cadence Vascular Closure Device

AccessClosure, the U.S. market leader in extravascular closure devices, announced today the launch of its next generation product, the Mynx Cadence Vascular Closure Device.

11 Jan 2011

Current and anticipated regulatory landscape for manufacturers of home healthcare equipment

Underwriters Laboratories (UL), a world leader in safety testing and certification, announced today the release of a white paper that addresses the current and anticipated regulatory landscape for manufacturers of home healthcare equipment. The white paper, "Home Healthcare Equipment: An Overview," examines the new IEC 60601-1-11 standard, and highlights the unique challenges for manufacturers with the U.S. Food and Drug Administration's (FDA) recently announced Medical Device Home Initiative.

11 Jan 2011

ESHRE Annual Meeting addresses latest breakthroughs in reproductive medicine

Reproductive medicine is one of today's most exciting scientific and clinical areas. Every month there are announcements of medical 'firsts', new rulings by regulatory bodies or ethical controversies. These often spark a heated debate among practitioners in the field, ethicists, legislators, the media and the public. ESHRE's Annual Meeting is the forum where more than 9,000 of the world's leading experts in reproductive medicine gather to give a public presentation of their latest research findings.

11 Jan 2011

OraSure to introduce QuickFlu test for detection of type A and type B influenza

OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.

11 Jan 2011

BioScale announces results of two pharmacodynamic biomarkers using assay AMMP technology

BioScale, an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, announced that results from the analysis of two pharmacodynamic biomarkers using the Acoustic Membrane MicroParticles assay technology on the ViBE Protein Analysis Workstation were published in the peer-reviewed Elsevier Journal of Analytical Biochemistry.

11 Jan 2011

First commercial deployment of Hotspur GPSCath Balloon Dilatation Catheter

Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter.

11 Jan 2011

Scientists create particles that resemble RBC, pave way for development of synthetic blood

A team of scientists has created particles that closely mirror some of the key properties of red blood cells, potentially helping pave the way for the development of synthetic blood.

11 Jan 2011

PakSense launches new class of temperature monitoring device

PakSense, an innovator in sensory solutions for packaging, announced today the launch of the PakSense BIOmed Label product line for use in clinical trials, pharmaceuticals, biologics, vaccines and other healthcare-related material transport.

11 Jan 2011

Singapore's NTU selects Agilent's RF test equipment for Virtus IC design centre of excellence

Agilent Technologies today announced that Singapore's Nanyang Technological University (NTU) has selected Agilent as the supplier of RF test equipment for its Virtus IC design centre of excellence. The move is designed to build a long-term relationship focusing on the growing education market in Asia.

11 Jan 2011

European CE Mark approval for IntraPace's abiliti system

IntraPace, announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity. The CE Mark certifies that a product has met European Union requirements for commercial marketing in Europe.

11 Jan 2011

Veeva introduces first combined pharma CRM and CLM solution for iPad

Today Veeva Systems unveiled Veeva iRep, the pharmaceutical industry's first complete customer relationship management (CRM) and closed loop marketing (CLM) solution built exclusively for the iPad. The new solution leverages the best of the iPad to drive efficiency through elegant CRM functionality, effectiveness via dynamic presentation of HTML5 content, and enhanced customer relationships with mobile internet connectivity.

11 Jan 2011

WellApps releases Colonoscopy Prep Assistant

WellApps, LLC, developer of GI Monitor for Crohn's and Ulcerative Colitis, announced today the release of Colonoscopy Prep Assistant. During the portion of colonoscopy preparation when a patient ingests a liquid laxative, Colonoscopy Prep Assistant tracks the number of glasses completed and time between glasses, notifying the patient when it's time to drink their next glass. The app is available for free in iTunes and the Android Market.

11 Jan 2011

Takeda, Zinfandel enter global licensing agreement for TOMM40 biomarker assay for Alzheimer's disease

Takeda Pharmaceutical Company Limited and Zinfandel Pharmaceuticals, Inc. today announced that they have entered into an exclusive, worldwide licensing agreement regarding Zinfandel's TOMM40 assay as a biomarker for the risk of Alzheimer's disease in high-risk older adults with normal cognition. The companies will study pioglitazone in connection with the TOMM40 biomarker and Alzheimer's disease.

11 Jan 2011

Novel scoring system identifies PTEN genetic mutation

Researchers have discovered a method for more precise identification of individuals who should undergo testing for genetic mutations of the tumor suppressor gene PTEN, which associates with a variety of conditions including several types of cancers. The research has created a diagnostic scoring system that improves on established criteria.

11 Jan 2011

Bristol-Myers Squibb, OPKO Health collaborate in relation to new diagnostic test technology

OPKO Health, Inc. today announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company relating to OPKO's new diagnostic test technology. OPKO's simple blood tests are being developed, based on its proprietary platform technology, to identify biomarkers for a wide variety of diseases including neurodegenerative disorders and various malignancies.

11 Jan 2011

Silicon microdevices may provide new way to screen metastatic breast cancer cells

Research by engineers and cancer biologists at Virginia Tech indicate that using specific silicon microdevices might provide a new way to screen breast cancer cells' ability to metastasize.

11 Jan 2011

Greenway selects DiagnosisONE to provide clinical decision support for EHR deployments

DiagnosisONE, the clinical decision support and analytics company, today announced that Greenway Medical Technologies, Inc., a leading provider of innovative electronic health record, ambulatory healthcare and clinical research business solutions, has selected DiagnosisONE to provide clinical decision support (CDS) for its electronic health record (EHR) deployments.

11 Jan 2011

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Physicians at Baylor Jack and Jane Hamilton Heart and Vascular Hospital are the first in North Texas to offer the Arctic Front® Cardiac CryoAblation Catheter system, the first and only cryoballoon in the United States indicated to treat drug refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF), a serious heart rhythm disorder that affects millions of Americans.

11 Jan 2011

Device / Technology News

HITRUST designates PwC as a Common Security Framework Assessor

Stereotaxis announces first successful cardiac ablation procedure with Vdrive robotic navigation system

AccessClosure launches Mynx Cadence Vascular Closure Device

Current and anticipated regulatory landscape for manufacturers of home healthcare equipment

ESHRE Annual Meeting addresses latest breakthroughs in reproductive medicine

OraSure to introduce QuickFlu test for detection of type A and type B influenza

BioScale announces results of two pharmacodynamic biomarkers using assay AMMP technology

First commercial deployment of Hotspur GPSCath Balloon Dilatation Catheter

Scientists create particles that resemble RBC, pave way for development of synthetic blood

PakSense launches new class of temperature monitoring device

Singapore's NTU selects Agilent's RF test equipment for Virtus IC design centre of excellence

European CE Mark approval for IntraPace's abiliti system

Veeva introduces first combined pharma CRM and CLM solution for iPad

WellApps releases Colonoscopy Prep Assistant

Takeda, Zinfandel enter global licensing agreement for TOMM40 biomarker assay for Alzheimer's disease

Novel scoring system identifies PTEN genetic mutation

Bristol-Myers Squibb, OPKO Health collaborate in relation to new diagnostic test technology

Silicon microdevices may provide new way to screen metastatic breast cancer cells

Greenway selects DiagnosisONE to provide clinical decision support for EHR deployments

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News